MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2023 International Congress

    Hearing impairment and non-motor symptoms in Parkinson’s disease: association and impact on quality of life

    E. Garasto, M. Conti, A. Viziano, A. Stefani, M. Pierantozzi, NB. Mercuri, A. Moleti, R. Sisto, T. Schirinzi, R. Cerroni (Rome, Italy)

    Objective: The aim of the study was to investigate the possible correlation between non-motor symptoms (NMS) burden and quality of life (QoL) with hearing impairment…
  • 2023 International Congress

    Gender inequities in people living with PD and their caregivers’ burden in Mexican population

    AJ. Hernández-Medrano, DP. Romero-Terán, MA. Ruiz-Mafud, MAG. Medrano-Delgado, MF. Medina-Pérez, AY. Regalado-Mustafá, DR. Aguila-Godinez, LG. Lira-Juarez, A. Domínguez-García, G. Hernández-Armesto, EC. Santiago-Delacruz, AA. Herrera-Ruiz, K. Talavera Lagunas, GI. Cerda-Hernández, A. Alcocer-Salas, JF. García-Hernández, RA. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (La Fama, Tlalpan, Mexico)

    Objective: To compare motor and non-motor dysfunction, quality of life (QoL), and caregiver burden (CB) between women and men living with PD, and its relationship…
  • 2023 International Congress

    Non-motor symptoms of Parkinson’s disease: an analysis of gender and age-related differences in a large online cohort

    D. Teixeira-Dos-Santos, G. Pereira, C. Rieder, A. Schumacher-Schuh (Porto Alegre, Brazil)

    Objective: This study analyzed non-motor symptoms in newly diagnosed Parkinson’s disease (PD) patients and controls in a large online cohort, comparing four groups based on…
  • 2023 International Congress

    Characteristics of Pain in Parkinson’s Disease with Arabic translation and validation of King’s Parkinson’s Disease Pain Scale

    T. Roushdy, E. Hamid, H. Salem, S. Reda, A. Shalash (cairo, Egypt)

    Objective: To translate and validate the King’s Parkinson’s Disease Pain Scale (KPPS) into Arabic and to correlate pain among PD patients with motor and non-motor…
  • 2023 International Congress

    Pain Phenomenon in Parkinson Disease

    R. Pinzon (Yogyakarta, Indonesia)

    Objective: To describe the phenomenon of pain disorder in Parkinson Disease patients. Background: Pain is one of the most common non-motor symptoms of Parkinson’s Disease…
  • 2023 International Congress

    Gender differences in REM Sleep Behavior Disorder in Parkinson’s disease

    EL. Ungureanu, ș. Diaconu, A. Zârnoveanu, R. Filip, M. Cușnir, B. Ciopleiaș, C. Falup-Pecurariu (Brasov, Romania)

    Objective: To study the gender differences in probable REM Sleep Behavior Disorder (RBD) and other sleep characteristics in a cohort of Parkinson’s disease (PD) patients.…
  • 2023 International Congress

    Utilizing Speech Analysis to Differentiate Progressive Supranuclear Palsy from Parkinson Disease

    K. Kang, A. Nunes, M. Sharma, A. Hall, R. Mishra, J. Casado, R. Cole, G. Barchard, A. Vaziri, A. Wills, A. Pantelyat (Baltimore, USA)

    Objective: To differentiate Progressive Supranuclear Palsy (PSP) from Parkinson Disease (PD) using speech analysis. Background: PD and PSP exhibit many clinical similarities including speech disorders…
  • 2023 International Congress

    Measuring the heterogeneity of disease progression in Parkinson’s disease with multimodal clinical milestones over 10 years in the DeNoPa cohort

    S. Weber, M. Dakna, A. Bednorz, M. Bartl, E. Lang, T. Wicke, M. Starke, J. Ebentheuer, F. Sixel-Döring, M. Muntean, S. Schade, C. Trenkwalder, B. Mollenhauer (Goettingen, Germany)

    Objective: To provide a reference of individual Parkinson’s disease (PD) progression by assessing multimodal milestones over 10 years (y) in patients of the DeNoPa cohort.…
  • 2023 International Congress

    Improvement of short-term satisfaction with life and treatment in Parkinson´s disease after subthalamic stimulation

    A. Sauerbier, P. Bachon, L. Ambrosio, P. Loehrer, A. Rizos, S. Jost, A. Gronostay, G. Fink, K. Ashkan, C. Nimsky, V. Visser-Vandewalle, K. Ray Chaudhuri, L. Timmermann, P. Martinez-Martin, H. Dafsari (Köln, Germany)

    Objective: The main aim of this study was to test the hypothesis that STN-DBS improves satisfaction with life and treatment in PD. Background: Subthalamic stimulation…
  • 2023 International Congress

    Parkinson’s disease-associated psychosis in a Brazilian sample: worse cognitive outcomes, higher LEDD and longer disease duration.

    H. Dourado, C. Lobo, G. Procópio, AE. Lima, MA. Silveira, L. de Almeida, IJ. Oliveira, G. Valença (Salvador, Brazil)

    Objective: To describe the prevalence of Parkinson's Disease (PD) associated psychosis (PDAP) at a Brazilian movement disorders outpatient and to evaluate its associated factors. Background:…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 55
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley